MannKind (MNKD) Investor Presentation - Slideshow

Oppenheimer 33rd Annual Healthcare Conference Michael Castagna, PharmD Chief Executive Officer March 14, 2023 NASDAQ: MNKD 1 © Copyright 2023. All rights reserved. MannKind Corporation. / 15 March 2023 Cautionary Statement Today's presentation includes forward-looking statements relating to the development, commercialization and benefits of our products and investigational product candidates, including AFREZZA®, that are subject to certain risks and uncertainties that could cause actual results to differ ma ...